The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
Fibromyalgia
Interventions
OTHER

Transcutaneous Posterior Tibial Nerve Stimulation + Duloxetine 30 MG

"PTNS was applied using two 50 mm × 50 mm electrode pads per extremity. The live pad was placed superior to and medial to the medial malleolus. The ground pad was placed 5-10 cm proximal to the live pad. The PTNS was applied using biphasic square waves with a frequency of 10 Hz and pulse duration of 200 μs. The amplitude was adjusted to the level that produced painless paresthesia in each patient according to their tolerance. PTNS was applied for 30 minutes~Duloxetine 30 mg p.o 1X1 (daily)"

DRUG

Duloxetine 30 MG

Duloxetine 30 mg p.o 1X1 (daily)

Trial Locations (2)

28200

Giresun University Faculty of Medicine, Giresun

55139

Ondokuz Mayıs University Faculty of Medicine, Samsun

All Listed Sponsors
lead

Ilker Fatih Sari

OTHER

NCT05937711 - The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia | Biotech Hunter | Biotech Hunter